Clinical Trial Update: Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cardiac sympathetic denervation to prevent ventricular tachyarrhythmias in patients at risk of sudden cardiac death.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Sudden Cardiac Death
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: University of California, Los Angeles | Conditions: Sudden Cardiac Death, Ventricular Tachycardia | Phase 3 | Status: UNKNOWN